Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
GTI Energy

Related Posts

Critical One Sells Uranium Assets to Dark Star,...

June 17, 2025

FinEx Metals

June 24, 2025

White House Unveils 90 Point AI Strategy

July 24, 2025

Group Eleven Announces C$5M Bought Deal Private Placement

July 22, 2025

Homerun Resources

February 24, 2026

More high grade gold intercepts at BMT3 in...

December 19, 2025

RZOLV Technologies Appoints Mary Ellen Thorburn to the...

December 12, 2025

Forte Minerals to Present at the Swiss Mining...

March 15, 2025

5 Biggest AI ETFs in 2025

March 6, 2025

Juggernaut Further Increases Oversubscribed Financing to $9,557,000 due...

April 26, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 2

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 5

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 6

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 7

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • Terms and conditions
    • Privacy Policy

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2026 daytradingreports.com | All Rights Reserved